Case number 2017-1715
Luitpold Pharmaceuticals, Inc. v. Pharmacosmos A/S > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | LUITPOLD PHARMACEUTICALS, INC. v. PHARMACOSMOS A/S [RULE 36 JUDGMENT] [nonprecedential] (0) |
| May 21, 2018 | 76 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [523105] [17-1715, 17-1725, 17-1786] [JAB] [Entered: 05/21/2018 09:55 AM] (0) |
| Apr 12, 2018 | 75 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Prost, Chief Judge; Wallach, Circuit Judge and Taranto, Circuit Judge). [512756] [17-1715, 17-1725] [JAB] [Entered: 04/12/2018 09:33 AM] (0) |
| Apr 6, 2018 | 74 | Submitted after ORAL ARGUMENT by George Ellsworth Quillin for Luitpold Pharmaceuticals, Inc. and Paul Ragusa for Pharmacosmos A/S. Panel: Judge: Prost , Judge: Wallach , Judge: Taranto. [511209] [JAB] [Entered: 04/06/2018 11:14 AM] (0) |
| Apr 5, 2018 | 73 | Entry of appearance for Natasha Iyer as of counsel for Appellant Luitpold Pharmaceuticals, Inc.. Service: 04/05/2018 by email. [510829] [17-1715] [Natasha Iyer] [Entered: 04/05/2018 11:11 AM] (0) |
| Mar 14, 2018 | 69 | Response to oral argument order from the Cross-Appellant Pharmacosmos A/S. designating Paul A. Ragusa as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [504916] [Paul Ragusa] [Entered: 03/14/2018 10:53 AM] (0) |
| Mar 14, 2018 | 70 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [69], ERROR: Counsel for cross-appellant Pharmacosmos A/S submitted a response to the oral argument order designating 15 minutes for argument and 5 minutes for rebuttal. The Oral Argument Order issued with the Notice of Calendaring states that unless otherwise directed by the court, total argument time is limited to 15 minutes per side. CORRECTION: Please promptly file a corrected response. [504934] [JAB] [Entered: 03/14/2018 11:11 AM] (0) |
| Mar 14, 2018 | 71 | CORRECTED Response to oral argument order from the Cross-Appellant Pharmacosmos A/S. designating Paul A. Ragusa as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [504941] [Paul Ragusa] [Entered: 03/14/2018 11:20 AM] (0) |
| Mar 14, 2018 | 72 | Response to oral argument order from the Appellant Luitpold Pharmaceuticals, Inc.. designating George E. Quillin as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [504973] [George Quillin] [Entered: 03/14/2018 12:44 PM] (0) |
| Feb 21, 2018 | 68 | NOTICE OF CALENDARING. Panel: 1804M. Case scheduled Apr 06, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 03/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [499761] [JAB] [Entered: 02/21/2018 01:12 PM] (0) |
| Nov 22, 2017 | 67 | 6 paper copies of the Joint Appendix [65] received from Appellant Luitpold Pharmaceuticals, Inc. [477758] [CW] [Entered: 11/22/2017 10:45 AM] (0) |
| Nov 21, 2017 | 66 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: certificate of interest Docket No. [64], ERROR: COI form submitted is outdated. CORRECTION: For future filings, please ensure the most up-to-date version of the form is used. [477275] [FMS] [Entered: 11/21/2017 09:29 AM] (0) |
| Nov 20, 2017 | 64 | Amended Certificate of Interest for the Cross-Appellant Pharmacosmos A/S. Service: 11/20/2017 by email. [477178] [Paul Ragusa] [Entered: 11/20/2017 06:09 PM] (3) |
| Nov 20, 2017 | 63 | 6 paper copies of the Reply Brief [58] received from Cross-Appellant Pharmacosmos A/S. [477051] [CW] [Entered: 11/20/2017 02:29 PM] (0) |
| Nov 20, 2017 | 62 | Certificate of Compliance with Fed. Cir. Rule 17 for Cross-Appellant Pharmacosmos A/S. Service: 11/20/2017 by email. [476992] [Paul Ragusa] [Entered: 11/20/2017 12:56 PM] (3) |
| Nov 20, 2017 | 61 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Luitpold Pharmaceuticals, Inc.. Service: 11/20/2017 by email. [476934] [George Quillin] [Entered: 11/20/2017 11:50 AM] (3) |
| Nov 20, 2017 | 60 | Certificate of Compliance with Fed. Cir. R. 17 (Agency) for Appellant Luitpold Pharmaceuticals, Inc.. Service: 11/20/2017 by email. [476923] [George Quillin] [Entered: 11/20/2017 11:10 AM] (3) |
| Nov 17, 2017 | 65 | APPENDIX FILED for Luitpold Pharmaceuticals, Inc. [59]. Number of Pages: 723. Service: 11/17/2017 by email. The paper copies of the brief should be received by the court on or before 11/30/2017. [477269] [FMS] [Entered: 11/21/2017 09:23 AM] (723) |
| Nov 17, 2017 | 59 | TENDERED from Appellant Luitpold Pharmaceuticals, Inc.. Title: JOINT APPENDIX. Service: 11/17/2017 by email. [476742] [George Quillin] [Entered: 11/17/2017 04:10 PM] (723) |
| Nov 13, 2017 | 58 | REPLY BRIEF FILED for Cross-Appellant Pharmacosmos A/S [57]. Number of Pages: 16. Service: 11/13/2017 by email. The paper copies of the brief should be received by the court on or before 11/21/2017. Appendix is due 11/20/2017. [475315] [FMS] [Entered: 11/14/2017 12:49 PM] (23) |
| Nov 13, 2017 | 57 | TENDERED from Cross-Appellant Pharmacosmos A/S. Title: REPLY BRIEF. Service: 11/13/2017 by email. [475045] [Paul Ragusa] [Entered: 11/13/2017 06:56 PM] (23) |
| Nov 6, 2017 | 56 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Luitpold Pharmaceuticals, Inc.. Service: 11/06/2017 by email. [473363] [Bradley Roush] [Entered: 11/06/2017 03:15 PM] (2) |
| Nov 2, 2017 | 55 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Cross-Appellant Pharmacosmos A/S. Service: 11/02/2017 by email. [472497] [Paul Ragusa] [Entered: 11/02/2017 01:42 PM] (2) |
| Nov 2, 2017 | 54 | 6 paper copies of the Corrected Reply Brief [53] received from Appellant Luitpold Pharmaceuticals, Inc. [472429] [CW] [Entered: 11/02/2017 12:06 PM] (0) |
| Oct 30, 2017 | 53 | CORRECTED REPLY BRIEF FILED for Appellant Luitpold Pharmaceuticals, Inc. [52]. Number of Pages: 52. Service: 10/30/2017 by email. The paper copies of the brief should be received by the court on or before 11/07/2017. Cross-Appellant's reply brief is due 11/13/2017. [471970] [FMS] [Entered: 10/31/2017 02:32 PM] (62) |
| Oct 30, 2017 | 52 | TENDERED from Appellant Luitpold Pharmaceuticals, Inc.. Title: CORRECTED REPLY BRIEF. Service: 10/30/2017 by email. [471653] [Bradley Roush] [Entered: 10/30/2017 07:39 PM] (62) |
| Oct 30, 2017 | 51 | Notice of Correction to the Brief Doc No. [50] for Appellant Luitpold Pharmaceuticals, Inc.. Service: 10/30/2017 by email. [471651] [Bradley Roush] [Entered: 10/30/2017 07:38 PM] (3) |
| Oct 30, 2017 | 50 | TENDERED from Appellant Luitpold Pharmaceuticals, Inc.. Title: REPLY BRIEF. Service: 10/30/2017 by email. [471546] [Bradley Roush] [Entered: 10/30/2017 04:53 PM] (0) |
| Oct 11, 2017 | 49 | ORDER filed. The motion [47] is granted. Luitpold Pharmaceuticals, Inc.'s response and reply brief is due October 30, 2017. Service: 10/11/2017 by clerk. [467090] [LMS] [Entered: 10/11/2017 04:02 PM] (2) |
| Oct 6, 2017 | 48 | RESPONSE of Cross-Appellant Pharmacosmos A/S to the motion to extend time to file reply brief [47] filed by Appellant Luitpold Pharmaceuticals, Inc. in 17-1715. Service: 10/06/2017 by email. [466265] [Paul Ragusa] [Entered: 10/06/2017 05:15 PM] (5) |
| Oct 6, 2017 | 47 | MOTION of Appellant Luitpold Pharmaceuticals, Inc. to extend the time to 10/30/2017 to file the reply brief. Any response is due within 10 days of service [Consent: opposed]. Service: 10/06/2017 by email. [466060] [George Quillin] [Entered: 10/06/2017 10:52 AM] (6) |
| Sep 11, 2017 | 46 | 6 paper copies of the Opening Response Brief [45] received from Cross-Appellant Pharmacosmos A/S. [460065] [CW] [Entered: 09/11/2017 11:27 AM] (0) |
| Sep 5, 2017 | 45 | BRIEF FILED for Cross-Appellant Pharmacosmos A/S [44]. Number of Pages: 75. Service: 09/05/2017 by email. The paper copies of the brief should be received by the court on or before 09/13/2017. Appellant's reply brief is due 10/16/2017. [459056] [FMS] [Entered: 09/06/2017 04:06 PM] (86) |
| Sep 5, 2017 | 44 | TENDERED from Cross-Appellant Pharmacosmos A/S. Title: RESPONSE BRIEF. Service: 09/05/2017 by email. [458754] [Lisa Kole] [Entered: 09/05/2017 07:18 PM] (86) |
| Aug 1, 2017 | 43 | 6 paper copies of the Opening Brief [42] received from Appellant Luitpold Pharmaceuticals, Inc.. [450806] [FMS] [Entered: 08/02/2017 08:59 AM] (0) |
| Jul 27, 2017 | 42 | BRIEF FILED for Appellant Luitpold Pharmaceuticals, Inc. [41]. Number of Pages: 39. Service: 07/27/2017 by email. The paper copies of the brief should be received by the court on or before 08/07/2017. Cross-Appellant Pharmacosmos A/S brief is due 09/05/2017. [450312] [FMS] [Entered: 07/31/2017 10:33 AM] (164) |
| Jul 27, 2017 | 41 | TENDERED from Appellant Luitpold Pharmaceuticals, Inc.. Title: OPENING BRIEF. Service: 07/27/2017 by email. [449802] [Bradley Roush] [Entered: 07/27/2017 04:44 PM] (164) |
| Jul 10, 2017 | 40 | ORDER granting motion to extend time to file appellant/petitioner principal brief [38] filed by Appellant Luitpold Pharmaceuticals, Inc. Luitpold Pharmaceuticals, Inc.'s brief is due 07/27/2017. Service: 07/10/2017 by clerk. [445280] [NL] [Entered: 07/10/2017 03:00 PM] (2) |
| Jul 7, 2017 | 39 | RESPONSE of Cross-Appellant Pharmacosmos A/S to the motion to extend time to file appellant/petitioner principal brief [38] filed by Appellant Luitpold Pharmaceuticals, Inc. in 17-1715. Service: 07/07/2017 by email. [445004] [Lisa Kole] [Entered: 07/07/2017 04:32 PM] (6) |
| Jul 6, 2017 | 38 | MOTION of Appellant Luitpold Pharmaceuticals, Inc. to extend the time to 07/27/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/06/2017 by email. [444643] [George Quillin] [Entered: 07/06/2017 05:20 PM] (5) |
| Jun 27, 2017 | 37 | ORDER filed. The motion to dismiss [27] is denied. The motion to extend time [36] is granted. Luitpold's opening brief is due no later than July 13, 2017. Service: 06/27/2017 by clerk. [442437] [LMS] [Entered: 06/27/2017 01:37 PM] (2) |
| Jun 21, 2017 | 36 | MOTION of Appellant Luitpold Pharmaceuticals, Inc. to extend the time to 07/13/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: opposed]. Service: 06/21/2017 by email. [441227] [George Quillin] [Entered: 06/21/2017 06:33 PM] (5) |
| Jun 14, 2017 | 35 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [439268] [JCA] [Entered: 06/14/2017 03:41 PM] (0) |
| Jun 6, 2017 | 31 | MOTION of Appellant Luitpold Pharmaceuticals, Inc. to extend the time to 06/29/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/06/2017 by email. [436570] [George Quillin] [Entered: 06/06/2017 09:55 AM] (5) |
| Jun 6, 2017 | 32 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Luitpold Pharmaceuticals, Inc.. Service: 06/06/2017 by email. [436573] [George Quillin] [Entered: 06/06/2017 10:08 AM] (14) |
| Jun 6, 2017 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [31] filed by Appellant Luitpold Pharmaceuticals, Inc. Brief is due 06/29/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [436739] [FMS] [Entered: 06/06/2017 02:20 PM] (0) |
| Jun 6, 2017 | 34 | RESPONSE of Cross-Appellant Pharmacosmos A/S to the supplemental authority [32] filed by Appellant Luitpold Pharmaceuticals, Inc. in 17-1715. Service: 06/06/2017 by email. [436891] [Paul Ragusa] [Entered: 06/06/2017 06:21 PM] (2) |
| May 30, 2017 | 30 | REPLY of Appellant Luitpold Pharmaceuticals, Inc. to response filed by Cross-Appellant in 17-1715 , Doc. No [29], response filed by Cross-Appellant in 17-1715 , Doc. No [28]. Service: 05/30/2017 by email. [434831] [George Quillin] [Entered: 05/30/2017 11:37 AM] (25) |
| May 22, 2017 | 29 | RESPONSE of Cross-Appellant Pharmacosmos A/S to the motion to terminate cross/consolidated appeal [27] filed by Appellant Luitpold Pharmaceuticals, Inc. in 17-1715. Service: 05/22/2017 by email. [433327] [Lisa Kole] [Entered: 05/22/2017 07:29 PM] (16) |
| May 22, 2017 | 28 | RESPONSE of Cross-Appellant Pharmacosmos A/S to the motion to terminate cross/consolidated appeal [27] filed by Appellant Luitpold Pharmaceuticals, Inc. in 17-1715. Service: 05/22/2017 by email. [433321] [Lisa Kole] [Entered: 05/22/2017 06:46 PM] (351) |
| May 11, 2017 | 27 | MOTION of Appellant Luitpold Pharmaceuticals, Inc. to terminate cross/consolidated appeal. Any response is due within 10 days of service [Consent: opposed]. Service: 05/11/2017 by email. [430856] [Bradley Roush] [Entered: 05/11/2017 08:07 PM] (136) |
| Apr 11, 2017 | 26 | Certified list from the United States Patent and Trademark Office. Service: 04/11/2017 by email. Appellant/Petitioner's brief is due 06/15/2017. [423832] [FMS] [Entered: 04/13/2017 02:02 PM] (146) |
| Apr 4, 2017 | 25 | Official caption revised to add cross-appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [421432] [FMS] [Entered: 04/04/2017 04:00 PM] (0) |
| Mar 27, 2017 | 24 | Entry of appearance for Bradley D. Roush as of counsel for Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/27/2017 by email. [419108] [George Quillin] [Entered: 03/27/2017 12:57 PM] (2) |
| Mar 27, 2017 | 23 | Entry of appearance for George E. Quillin as of counsel for Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/27/2017 by email. [419107] [George Quillin] [Entered: 03/27/2017 12:56 PM] (2) |
| Mar 27, 2017 | 22 | Entry of appearance for Michael D. Kaminski as principal counsel for Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/27/2017 by email. [419105] [George Quillin] [Entered: 03/27/2017 12:54 PM] (2) |
| Mar 27, 2017 | 21 | Certificate of Interest for the Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/27/2017 by email. [419103] [George Quillin] [Entered: 03/27/2017 12:52 PM] (2) |
| Mar 27, 2017 | 20 | Docketing Statement for the Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/27/2017 by email. [419101] [George Quillin] [Entered: 03/27/2017 12:52 PM] (4) |
| Mar 24, 2017 | 19 | Note to file: The following cases are associated:17-1715 Lead with 17-1725 Consolidated, 17-1786 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [418870] [17-1715, 17-1725, 17-1786] [JCA] [Entered: 03/24/2017 04:16 PM] (0) |
| Mar 17, 2017 | 18 | Entry of appearance for Steven Lendaris as of counsel for Appellee Pharmacosmos A/S. Service: 03/17/2017 by email. [416508] [Steven Lendaris] [Entered: 03/17/2017 10:00 AM] (1) |
| Mar 17, 2017 | 17 | Entry of appearance for Paul A. Ragusa as principal counsel for Appellee Pharmacosmos A/S. Service: 03/17/2017 by email. [416505] [Paul Ragusa] [Entered: 03/17/2017 09:57 AM] (1) |
| Mar 16, 2017 | 16 | Docketing Statement for the Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416327] [Lisa Kole] [Entered: 03/16/2017 03:53 PM] (3) |
| Mar 16, 2017 | 15 | Corrected Entry of appearance for Jennifer C. Tempesta as of counsel for Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416323] [Jennifer Tempesta] [Entered: 03/16/2017 03:49 PM] (1) |
| Mar 16, 2017 | 14 | Corrected Entry of appearance for Lisa Kole as of counsel for Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416306] [Lisa Kole] [Entered: 03/16/2017 03:23 PM] (1) |
| Mar 16, 2017 | 13 | Corrected Certificate of Interest for the Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416303] [Lisa Kole] [Entered: 03/16/2017 03:21 PM] (1) |
| Mar 16, 2017 | 12 | Entry of appearance for Jennifer C. Tempesta as of counsel for Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416178] [Jennifer Tempesta] [Entered: 03/16/2017 12:35 PM] (1) |
| Mar 16, 2017 | 11 | Entry of appearance for Lisa Kole as of counsel for Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416174] [Lisa Kole] [Entered: 03/16/2017 12:31 PM] (1) |
| Mar 16, 2017 | 10 | Docketing Statement for the Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416170] [Lisa Kole] [Entered: 03/16/2017 12:30 PM] (3) |
| Mar 16, 2017 | 9 | Certificate of Interest for the Appellee Pharmacosmos A/S. Service: 03/16/2017 by email. [416167] [Lisa Kole] [Entered: 03/16/2017 12:29 PM] (1) |
| Mar 16, 2017 | 8 | Entry of appearance for Bradley D. Roush as of counsel for Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416161] [George Quillin] [Entered: 03/16/2017 12:24 PM] (2) |
| Mar 16, 2017 | 7 | Entry of appearance for George E. Quillin as of counsel for Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416159] [George Quillin] [Entered: 03/16/2017 12:22 PM] (2) |
| Mar 16, 2017 | 6 | Entry of appearance for Michael D. Kaminski as principal counsel for Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416156] [George Quillin] [Entered: 03/16/2017 12:20 PM] (2) |
| Mar 16, 2017 | 5 | Docketing Statement for the Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416152] [George Quillin] [Entered: 03/16/2017 12:18 PM] (4) |
| Mar 16, 2017 | 4 | Certificate of Interest for the Appellant Luitpold Pharmaceuticals, Inc.. Service: 03/16/2017 by email. [416150] [George Quillin] [Entered: 03/16/2017 12:17 PM] (2) |
| Mar 10, 2017 | 3 | Note to file: The following cases are associated:17-1715 Lead with 17-1725 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [414298] [17-1715, 17-1725] [JB] [Entered: 03/10/2017 11:02 AM] (0) |
| Mar 10, 2017 | 2 | ORDER consolidating appeals (17-1715 Lead with 17-1725 Consolidated). The above-captioned appeals appear to be related and thus one set of briefs should be filed for the two appeals. Service as of this date by Clerk of Court. [414285] [JB] [Entered: 03/10/2017 10:58 AM] (2) |
| Mar 2, 2017 | 1 | Appeal docketed. Received: 03/01/2017. [411881] Entry of Appearance due 03/16/2017. Certificate of Interest is due on 03/16/2017. Docketing Statement due 03/16/2017. Certified List due on 04/11/2017. [FMS] [Entered: 03/02/2017 10:07 AM] (7) |
